Search
01/05/2025
Metabolic dysfunction-and alcohol-associated steatotic liver disease is associated with higher risk of advanced fibrosis and mortality than metabolic dysfunction-associated steatotic liver disease: data from a large global biopsy-proven cohort
Younossi, Z, de Avila, L, Petta, S, Nakajima, A, Crespo, J, Kim, SU, Castera, L, Zheng, MH, Tsochatzis, E, Trivikrama, SK, Shalimar, S, Alswat, KA, Yilmaz, Y, Yu, ML, Francque, S, Chan, WK, Fernández, MIC, Treeprasertsuk, S, Duseja, AK, Gadano, A, Oliveira, CP, Arab, JP, Papatheodoridis, G, Diaz, LA, Sebastiani, G, D'Ambrosio, R, Valsan, A, Khalid, A, Holleboom, AG, El-Kassas, M, Pugliese, N, Singal, AK, Pearlman, B, Choudhary, NS, Cordie, A, Gunn, N, Caussy, C, Mauricio, D, Kawaguchi, T, Russo, FP, Venu, A, Hagström, H, Alkhouri, N, Ananchuensook, P, Mohan, L, Fan, JA, Roberts, S, Wong, VWS, Dunn, W, Ekstedt, M, Goh, GBB, Pessoa, M, Lampertico, P, Pennisi, G, Shang, Y, Liu, WY, Lee, HW, Kobayashi, T, Kakizaki, S, Iruzubieta, P, Nadeem, R, Cinque, F, Neonaki, A, Zoncapè, M, Yang, RX, Song, SJ, Dunn, N, Gadi, Z, Yeh, ML, Teh, KKJ, Mahadeva, S, Fabian, LG, Almohsen, A, Leite, N, Vessby, J, Xie, CC, Friend, E, Poca, M, Segrestin, B, Arrese, M, Lam, B, Racila, A, Alqahtani, S, Stepanova, M. Metabolic dysfunction-and alcohol-associated steatotic liver disease is associated with higher risk of advanced fibrosis and mortality than metabolic dysfunction-associated steatotic liver disease: data from a large global biopsy-proven cohort. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025
Phase angle as a predictive factor for mortality in hospitalized patients with cirrhosis
Javier, FO, Sánchez, J, Roman, E, Miquel, M, Kaur, N, Ferrusquía-Acosta, J, Poca, M, Solé, C, Cuyàs, B, Casas, M, Alvarado-Tapias, E, Monllor-Nunell, T, Sheila, A, Andreu, F, Brujats, A, Vergara, M, Escorsell, A, Soriano, G. Phase angle as a predictive factor for mortality in hospitalized patients with cirrhosis. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025
Dynamics and prognostic implications of splanchnic volumetry in patients withportosinusoidal vascular liver disorder
Ferrusqu a-Acosta, J, Gil-Bello, D, Lampichler, K, Vidal, M, Fuertes, D, Simonis, L, Wu, CJ, Shen, Y, Luo, XF, G mez, FT, Parada-Bl zquez, MJ, Gir ldez-Gallego, A, S nchez-Lorenzo, A, Selva-Tal n, D, Alvarado-Tapias, E, Saltini, D, Squecco, D, Schepis, F, Giudicelli, H, Wagner, M, Thabut, D, Garc a-Calonge, M, Uceda-Andr s, E, Alvarez-Navascu s, C, Koc, O, Miclea, R, Maderuelo, E, Herrera, EL, Casas, M, Miquel, M, Vergara, M, Balcar, L, S nchez, J, Sol , C, Scheiner, B. Dynamics and prognostic implications of splanchnic volumetry in patients withportosinusoidal vascular liver disorder. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025
Anemia following portal hypertension-related bleeding in liver cirrhosis: incidence and impact on prognosis
Ojeda, A, Magaz, M, Agulleiro, I, Pascual, I, Jimenez-Esquivel, N, Pèlach, A, Cháfer, IT, García-García, S, Maderuelo, E, Puente, A, Cobreros, M, Gonzalez, JV, Amador, A, Alvarado-Tapias, E, Gonzílez-Alayón, C, Téllez, L, Manzano, F, Bernal, V, Lomas, R, Ferrusquía-Acosta, J, Perez, V, Shalaby, S, Baiges, A, Turon, F, Hernández-Gea, V, Romero-Gutiérrez, M, Vives-Moreno, J, Albillos, A, Morant, A, Alonso, JC, Simón-Talero, M, Fortea, J, Herrera, EL, Aguilera, V, Masnou, H, Giráldez-Gallego, A, García-Pagán, JC. Anemia following portal hypertension-related bleeding in liver cirrhosis: incidence and impact on prognosis. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025
A global analysis of patients with metabolic dysfunction associated steatotic liver disease with liver biopsy, non-invasive tests and mortality
Younossi, Z, de Avila, L, Petta, S, Hagström, H, Kim, SU, Nakajima, A, Crespo, J, Castera, L, Alkhouri, N, Zheng, MH, Treeprasertsuk, S, Ananchuensook, P, Shalimar, S, Tsochatzis, E, Trivikrama, SK, Mohan, L, Fan, JA, Roberts, S, Alswat, KA, Wong, VWS, Yilmaz, Y, Dunn, W, Francque, S, Cordie, A, Yu, ML, Ekstedt, M, Goh, GBB, Oliveira, CP, Pessoa, M, Chan, WK, Fernández, MIC, Duseja, AK, Arab, JP, Papatheodoridis, G, Sebastiani, G, Villela-Nogueira, C, D'Ambrosio, R, Lampertico, P, Khalid, A, Holleboom, AG, Valsan, A, El-Kassas, M, Pennisi, G, Shang, Y, Liu, WY, Lee, HW, Kobayashi, T, Kakizaki, S, Caussy, C, Pearlman, B, Iruzubieta, P, Nadeem, R, Cinque, F, Neonaki, A, Zoncapè, M, Yang, RX, Song, SJ, Dunn, N, Gadi, Z, Yeh, ML, Teh, KKJ, Mahadeva, S, Fabian, LG, Almohsen, A, Leite, N, Pugliese, N, Vessby, J, Xie, CC, Choudhary, NS, Friend, E, Poca, M, Kawaguchi, T, Russo, FP, Gadano, A, Singal, AK, Diaz, LA, Ségrestin, B, Gunn, N, Mauricio, D, Arrese, M, Lam, B, Racila, A, Alqahtani, S, Stepanova, M. A global analysis of patients with metabolic dysfunction associated steatotic liver disease with liver biopsy, non-invasive tests and mortality. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025
Secular trends in periprosthetic joint infections following primary hip and knee arthroplasties: A 15-year cohort study from the VINCat Program (2008-2022)
López-Contrerasa, J, Lloracha, PD, Villaverde, NR, Almendral, A, López, AF, Marimon, M, Domínguez-Luzón, MA, Martinez-Pastor, JC, Salas, JR, Benito, N, Morata, L, Zules-Oña, R, Limón, E, Pujol, M. Secular trends in periprosthetic joint infections following primary hip and knee arthroplasties: A 15-year cohort study from the VINCat Program (2008-2022). ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2025; 43DOI:10.1016/j.eimc.2025.02.007. PMID:40316368. IF:2.500(Q2/5D).
01/05/2025
The in vitro immune response of mononuclear cells to Escherichia coli is not dependent on antibiotic multidrug resistance
Cuyas, B, Cant , E, Sanchez, E, Mir , E, Alvarado-Tapias, E, Roman, E, Poca, M, Navarro, F, Escorsell, A, Vidal, S, Soriano, G. The in vitro immune response of mononuclear cells to Escherichia coli is not dependent on antibiotic multidrug resistance. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025
Surveillance of catheter-related bacteremia in VINCat program
Gasch, O, Almendral, A, Andrés, M, Càmara, J, Domenech, D, Garcia-Alarcon, X, García-Quesada, MJ, Jiménez-Martínez, E, Marrón, A, Moreno, E, Pomar, V, Vaqué, M, Limón, E, Pujol, M. Surveillance of catheter-related bacteremia in VINCat program. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2025; 43DOI:10.1016/j.eimc.2024.12.001. PMID:. IF:2.500(Q2/5D).
01/05/2025
Real-World Evidence for Fixed Triple Therapy With Beclomethasone/Formoterol/Glycopyrronium in Asthma Patients With Concomitant COPD: Six-Month Results of Trimaximize
Gessner, C, Bogoevska,, Russell, R, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Fritz, C, Hahn, A, Trinkmann, F. Real-World Evidence for Fixed Triple Therapy With Beclomethasone/Formoterol/Glycopyrronium in Asthma Patients With Concomitant COPD: Six-Month Results of Trimaximize. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2025; 211DOI:10.1164/ajrccm.2025.211.Abstracts.A3500. PMID:. IF:19.400(Q1/1D).
01/05/2025
Mortality Predictors in Thoracic Sarcoidosis: Results From SARCO-1 Registry
Torres, JS, Ramos, D, Francesqui, J, De Miguel, EB, Villar, A, Florez, P, Balcells, E, Pinillos-Robles, E, Castaño, G, Mayoral, RG, Muñiz, BL, Soler-Sampere, M, Castillo, D, Rafecas-Codern, A, Mariscal, P, Millan-Billi, P, Portillo, K, Hernandez, F. Mortality Predictors in Thoracic Sarcoidosis: Results From SARCO-1 Registry. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2025; 211DOI:10.1164/ajrccm.2025.211.Abstracts.A1842. PMID:. IF:19.400(Q1/1D).
01/05/2025
Phenotype Analysis of Chronic Bronchial Infection Patients on Nebulized Antibiotic Therapy: A Multicenter Retrospective Cohort Study in Spain (INBREATHING Study)
Gonzalez, J, Moreno, BR, Benítez, I, Erro, M, Burgos, J, Sayés, A, García, EJ, Pou, C, Castañon, R, Navarro, A, de las Uentes, AM, Lakhani, JS, Hernández, A, Manzano, C, Santisteve, S, Monge, A, Moix, AM, Sánchez-Cucó, A, Alcaide, A, Tajos, JD, Barbe, F, Suárez, G, de la Rosa, D. Phenotype Analysis of Chronic Bronchial Infection Patients on Nebulized Antibiotic Therapy: A Multicenter Retrospective Cohort Study in Spain (INBREATHING Study). AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2025; 211DOI:10.1164/ajrccm.2025.211.Abstracts.A5149. PMID:. IF:19.400(Q1/1D).
01/05/2025
Dupilumab Improves Health-related Quality of Life and Asthma Control in Patients With and Without Coexisting Type 2 Conditions: Results From the RAPID Study
Cote, A, Mosnaim, GS, Lugogo, NL, Price, D, Plaza, V, Changming, X, Awad, H, Kwah, J. Dupilumab Improves Health-related Quality of Life and Asthma Control in Patients With and Without Coexisting Type 2 Conditions: Results From the RAPID Study. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2025; 211DOI:10.1164/ajrccm.2025.211.Abstracts.A1399. PMID:. IF:19.400(Q1/1D).
01/05/2025
Strategies for early detection and detailed characterization of oral lesions and head and neck squamous cell carcinoma in Fanconi anemia patients
Beddok, A, Velleuer, E, Fontbrune, FSD, Brakenhoff, RH, Dalle, JH, Dufour, C, Faivre, S, Genet, C, Klijanienko, J, Krieg, C, Leblanc, T, Martinez, P, Latour, RP, Rigolet, A, Saintigny, P, Lyonnet, DS, Soulier, J, Surralles, J, Schramm, M, Thariat, J. Strategies for early detection and detailed characterization of oral lesions and head and neck squamous cell carcinoma in Fanconi anemia patients. CANCER LETTERS. 2025; 617DOI:10.1016/j.canlet.2025.217529. PMID:40054658. IF:10.100(Q1/1D).
01/05/2025
Real-world treatment patterns, survival outcomes, and health care resource utilization for locally advanced or metastatic urothelial carcinoma in Spain
Puente, J, Pinto, A, Mendez-Vidal, MJ, del Muro, XG, Maroto, P, Vazquez, S, Luque-Caro, R, Anido, U, Strunz-McKendry, T, Upadhyay, A, Montes, J, Nuñez, AO, Portela, JG, Castellano, D. Real-world treatment patterns, survival outcomes, and health care resource utilization for locally advanced or metastatic urothelial carcinoma in Spain. Clinical & Translational Oncology. 2025; 27(5)DOI:10.1007/s12094-024-03734-8. PMID:39365365. IF:2.500(Q3/6D).
01/05/2025
Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC
Cappuzzo, F, Zvirbule, Z, Korbenfeld, E, Kolb-Sielecki, J, Isla, D, Szczesna, A, Sanchez, AYC, Bustillos, A, Liu, XY, Young, F, Tosti, N, Monteiro, MF, Majem, M. Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC. Jto Clinical And Research Reports. 2025; 6(5)DOI:10.1016/j.jtocrr.2025.100815. PMID:40248457. IF:(Q/D).
01/05/2025
Targeting the chemokine receptor CXCR4 for cancer therapies
Rueda, A, Serna, N, Mangues, R, Villaverde, A, Unzueta, U. Targeting the chemokine receptor CXCR4 for cancer therapies. Biomarker Research. 2025; 13(1)DOI:10.1186/s40364-025-00778-y. PMID:40307933. IF:11.500(Q1/1D).
01/05/2025
D816V KIT mutation induces mitochondrial morphologic and functional changes through BNIP3 downregulation in human myeloid cell lines ROSA and TF-1
Wieczorek, SC, Hernández-Alvarez, MI, Parreño, M, Muñoz, JP, Bussaglia, E, Carricondo, M, Ubeda, J, Dubreuil, P, Zorzano, A, Brenet, F, Nomdedeu, JF. D816V KIT mutation induces mitochondrial morphologic and functional changes through BNIP3 downregulation in human myeloid cell lines ROSA and TF-1. EXPERIMENTAL HEMATOLOGY. 2025; 145DOI:10.1016/j.exphem.2025.104748. PMID:39986568. IF:2.100(Q3/6D).
01/05/2025
Association of human papillomavirus infection with the occurrence of second neoplasms and their prognostic impact in patients with oropharyngeal carcinoma
Gayà, J, Rubio, D, Valero, C, Vázquez-López, C, Holgado, A, Quer, M, León, X. Association of human papillomavirus infection with the occurrence of second neoplasms and their prognostic impact in patients with oropharyngeal carcinoma. Acta Otorrinolaringologica Espanola. 2025; 76(3)DOI:10.1016/j.otorri.2025.512237. PMID:40127862. IF:(Q/D).
01/05/2025
Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance
Sobas, MA, Turki, AT, Ramiro, AV, Hernández-Sánchez, A, Elicegui, JM, González, T, Melchor, RA, Abáigar, M, Tur, L, Dall'Olio, D, Sträng, E, Tettero, JM, Castellani, G, Benner, A, Doehner, K, Thiede, C, Metzeler, KH, Haferlach, T, Damm, F, Ayala, R, Martínez-López, J, Mills, KI, Sierra, J, Lehmann, S, Della Porta, MG, Mayer, J, Reinhardt, D, Medina, RV, Schulze-Rath, R, Barbus, M, Hernández-Rivas, JM, Huntly, BJP, Ossenkoppele, G, Döhner, H, Bullinger, L. Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance. HAEMATOLOGICA. 2025; 110(5)DOI:10.3324/haematol.2024.285805. PMID:39506894. IF:10.100(Q1/2D).
01/05/2025
Expert consensus on patterns of progression in kidney cancer after adjuvant immunotherapy and subsequent treatment strategies
Alonso-Gordoa, T, Anguera, G, Domínguez-Esteban, M, Reig, O, Martínez-Barros, H, Molina-Cerrillo, J, Cruz, P, Maroto, P. Expert consensus on patterns of progression in kidney cancer after adjuvant immunotherapy and subsequent treatment strategies. CANCER TREATMENT REVIEWS. 2025; 136DOI:10.1016/j.ctrv.2025.102925. PMID:40186886. IF:10.500(Q1/1D).